help button home button Am J Pathol PCR Enhanced. PCRboost from Biomatrica
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krause, P. J.
Right arrow Articles by Kreutzer, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krause, P. J.
Right arrow Articles by Kreutzer, D. L.

American Journal of Pathology, Vol 129, 217-222, Copyright © 1987 by American Society for Investigative Pathology


REGULAR ARTICLES

Pentoxifylline enhancement of defective neutrophil function and host defense in neonatal mice

PJ Krause, J Kristie, WP Wang, L Eisenfeld, VC Herson, EG Maderazo, K Jozaki and DL Kreutzer
Department of Pediatrics, Hartford Hospital, Connecticut.

Decreased neutrophil (PMN) chemotaxis is thought to contribute to the increased morbidity and mortality from infection in newborn infants. Pentoxifylline, a methylxanthine, has previously been shown to augment PMN chemotaxis in vitro. The authors therefore investigated the effects of pentoxifylline on 1) in vitro PMN chemotaxis, 2) in vivo leukocyte accumulation, and 3) protection against Staphylococcus aureus infection in newborn mice. Using a modified Boyden chamber system, they demonstrated that pentoxifylline significantly enhanced neonatal PMN chemotaxis in a dose-dependent manner. Additionally, pentoxifylline was found to increase PMN accumulation in vivo in a proteose peptone- induced peritonitis model. Finally, the survival rate in experimentally induced S aureus infection was 51% in neonatal mice given pentoxifylline, compared with 17% in a control (nonpentoxifylline) group (P less than 0.01). These data demonstrate pentoxifylline modulation of PMN migration and enhancement of host defense against bacterial infection.


This article has been cited by other articles:


Home page
J. Virol.Home page
W. B. Klimstra, K. D. Ryman, K. A. Bernard, K. B. Nguyen, C. A. Biron, and R. E. Johnston
Infection of Neonatal Mice with Sindbis Virus Results in a Systemic Inflammatory Response Syndrome
J. Virol., December 1, 1999; 73(12): 10387 - 10398.
[Abstract] [Full Text]


Home page
J. Appl. Physiol.Home page
C. A. Hales, T. H. Elsasser, P. Ocampo, and O. Efimova
TNF-alpha in smoke inhalation lung injury
J Appl Physiol, May 1, 1997; 82(5): 1433 - 1437.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by the American Society for Investigative Pathology.